Increasing Macrolide and Fluoroquinolone Resistance in Mycoplasma genitalium

Escalating resistance to azithromycin and moxifloxacin is being reported for Mycoplasma genitalium in the Asia-Pacific region. Analyzing 140 infections, we found pretreatment fluoroquinolone-resistance mutations in parC (13.6%) and gyrA (5%). ParC S83 changes were associated with moxifloxacin failur...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Emerg Infect Dis
Egile Nagusiak: Murray, Gerald L., Bradshaw, Catriona S., Bissessor, Melanie, Danielewski, Jennifer, Garland, Suzanne M., Jensen, Jørgen S., Fairley, Christopher K., Tabrizi, Sepehr N.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Centers for Disease Control and Prevention 2017
Gaiak:
Dispatch
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5403035/
https://ncbi.nlm.nih.gov/pubmed/28418319
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3201/eid2305.161745
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak